Chabiotech Co.,Ltd. (KOSDAQ:085660)
11,080
+230 (2.12%)
Aug 14, 2025, 3:30 PM KST
Chabiotech Market Cap
Chabiotech has a market cap or net worth of 846.80 billion as of August 15, 2025. Its market cap has decreased by -8.09% in one year.
Market Cap
846.80B
Enterprise Value
1.82T
Revenue
1.12T
Ranking
n/a
PE Ratio
n/a
Stock Price
11,080.00
Market Cap Chart
Since February 23, 2009, Chabiotech's market cap has increased from 334.13B to 846.80B, an increase of 153.43%. That is a compound annual growth rate of 5.80%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 14, 2025 | 846.80B | 32.01% |
Dec 30, 2024 | 641.46B | -41.85% |
Dec 28, 2023 | 1,103.20B | 50.82% |
Dec 29, 2022 | 731.49B | -34.83% |
Dec 30, 2021 | 1,122.40B | 6.53% |
Dec 30, 2020 | 1,053.61B | 39.68% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 73.52T |
Celltrion | 38.58T |
ALTEOGEN | 23.35T |
Yuhan | 8,561.74B |
Peptron | 8,235.61B |
SK Biopharmaceuticals | 7,878.31B |
PharmaResearch | 7,106.52B |
LigaChem Biosciences | 5,666.20B |